Nexell Therapeutics Inc – ‘8-K’ for 4/18/97 – EX-16

As of:  Wednesday, 5/21/97   ·   For:  4/18/97   ·   Accession #:  864009-97-12   ·   File #:  0-28124

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         2     10K 
 2: EX-16       Letter From Richard A. Eisner & Co. L.L.P.             1      4K 

EX-16   —   Letter From Richard A. Eisner & Co. L.L.P.

 {LETTERHEAD OF RICHARD A. EISNER & CO., L.L.P.}

                                                    May 20, 1997

VIMRX Pharmaceuticals Inc.                                    
2751 Centerville Road, Suite 210                              
Wilmington, Delaware 19808                                    

Dear Sirs and Mesdames:                                       

             We have read the statements made by VIMRx  Pharmaceuticals  Inc. in
          Item 4 of the  accompanying  Form 8-K  which is being  filed  with the
          Securities  and  Exchange  Commission.  We agree  with the  statements
concerning our Firm.                                        

                           Very truly yours,

                                             /s/ RICHARD A. EISNER & CO., L.L.P.

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing		Date		Other Filings
Filed on:		5/21/97
		5/20/97
For Period End:		4/18/97		S-3
				List all Filings